| Dr Amanda Lynn Hernandez-jones, MD, PHD | |
|
263 Farmington Ave, Farmington, CT 06030-8031 | |
| (860) 679-4888 | |
| (860) 679-1462 |
| Full Name | Dr Amanda Lynn Hernandez-jones |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 8 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861849473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 66261 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).
› Verified 2 days ago
| Entity Name | Middlesex Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972563138 PECOS PAC ID: 5092611731 Enrollment ID: O20031216000592 |
News Archive
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).
› Verified 2 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Lynn Hernandez-jones, MD, PHD 263 Farmington Ave, Farmington, CT 06030-8082 Ph: (860) 697-4888 | Dr Amanda Lynn Hernandez-jones, MD, PHD 263 Farmington Ave, Farmington, CT 06030-8031 Ph: (860) 679-4888 |
News Archive
Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.
The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).
› Verified 2 days ago
William P Shea Iii, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Kristina Frances Victoria Zdanys, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Psychiatry, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Marie Carl Eugene, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Neurology Mc-3835, Farmington, CT 06030 Phone: 860-679-4888 Fax: 860-679-1042 | |
Kelly Nicole Stinson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Talcott Notch Rd, Farmington, CT 06032 Phone: 860-679-6700 Fax: 860-679-6736 | |
Feier Liu, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Gema Guanco, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 270 Farmington Ave, Suite 309, Farmington, CT 06032 Phone: 860-677-5570 Fax: 860-677-9570 | |
Dr. Asante Kofi Mendes, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2000 |